Atlas Trials

Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

Clinical trial NCT07070765 · RECRUITING

Trial details

NCT number
NCT07070765
Sponsor
University of Aberdeen
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2025-12-12
Primary completion
2028-10-31
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.